{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:44:19Z","timestamp":1792424659636,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.cca.2017.09.005","type":"journal-article","created":{"date-parts":[[2017,9,10]],"date-time":"2017-09-10T14:46:16Z","timestamp":1505054776000},"page":"108-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Phosphorus and mortality risk in end-stage renal disease: A meta-analysis"],"prefix":"10.1016","volume":"474","author":[{"given":"Yue","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2017.09.005_bb0005","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(16)30448-2","article-title":"Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices","volume":"388","author":"Robinson","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2017.09.005_bb0010","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1681\/ASN.2014101017","article-title":"Maintenance dialysis throughout the world in years 1990 and 2010","volume":"26","author":"Thomas","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2017.09.005_bb0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"Cheung","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2017.09.005_bb0020","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2017.09.005_bb0025","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1097\/01.ASN.0000019641.41496.1E","article-title":"Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study","volume":"13","author":"Longenecker","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2017.09.005_bb0030","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/nu5031002","article-title":"Mineral metabolic abnormalities and mortality in dialysis patients","volume":"5","author":"Abe","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.cca.2017.09.005_bb0035","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/bonekey.2015.74","article-title":"Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity","volume":"4","author":"Brown","year":"2015","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.cca.2017.09.005_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cca.2017.09.005_bb0045","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1681\/ASN.2007020143","article-title":"Hypophosphatemia: clinical consequences and management","volume":"18","author":"Brunelli","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2017.09.005_bb0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.ajkd.2005.04.006","article-title":"Mild hyperphosphatemia and mortality in hemodialysis patients","volume":"46","author":"Rodriguez-Benot","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2017.09.005_bb0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.ki.5001542","article-title":"Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study","volume":"70","author":"Melamed","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2017.09.005_bb0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1542-4758.2007.00190.x","article-title":"Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study","volume":"11","author":"Kimata","year":"2007","journal-title":"Hemodial. Int. Int. Symp. Home Hemodial."},{"key":"10.1016\/j.cca.2017.09.005_bb0065","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2017.09.005_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2010.08.037","article-title":"Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry","volume":"57","author":"Tangri","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2017.09.005_bb0075","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2017.09.005_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116273","article-title":"Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study","volume":"9","author":"Sakaguchi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2017.09.005_bb0085","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","article-title":"Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study","volume":"30","author":"Fernandez-Martin","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2017.09.005_bb0090","doi-asserted-by":"crossref","DOI":"10.1007\/s11255-017-1558-2","article-title":"Hypophosphatemia: nutritional status, body composition, and mortality in hemodialysis patients","author":"Garagarza","year":"2017","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.cca.2017.09.005_bb0095","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2017.09.005_bb0100","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.ajkd.2015.01.009","article-title":"Serum phosphorus and progression of CKD and mortality: a meta-analysis of cohort studies","volume":"66","author":"Da","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2017.09.005_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2369-14-88","article-title":"Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis","volume":"14","author":"Natoli","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.cca.2017.09.005_bb0110","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2017.09.005_bb0115","author":"Wells"},{"key":"10.1016\/j.cca.2017.09.005_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfw387","article-title":"Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis","author":"Pichler","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2017.09.005_bb0125","doi-asserted-by":"crossref","first-page":"35375","DOI":"10.1038\/srep35375","article-title":"Aortic arch calcification and risk of cardiovascular or all-cause and mortality in dialysis patients: a meta-analysis","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2017.09.005_bb0130","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1681\/ASN.V13suppl_1s28","article-title":"Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients","volume":"13","author":"Qureshi","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2017.09.005_bb0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.ajkd.2003.08.045","article-title":"Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD","volume":"43","author":"Cooper","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2017.09.005_bb0140","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2017.09.005_bb0145","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/ndt\/gfv414","article-title":"Phosphorus metabolism in peritoneal dialysis- and haemodialysis-treated patients","volume":"31","author":"Evenepoel","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2017.09.005_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000444890","article-title":"Changes in markers of mineral and bone disorders and mortality in incident hemodialysis patients","volume":"43","author":"Soohoo","year":"2016","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cca.2017.09.005_bb0155","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2017.09.005_bb0160","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117303510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117303510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T15:49:27Z","timestamp":1659455367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117303510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":32,"alternative-id":["S0009898117303510"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.09.005","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphorus and mortality risk in end-stage renal disease: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}